The ideal mHealth-application for rheumatoid arthritis: qualitative findings from stakeholder focus groups

Michaël Doumen, René Westhovens, Sofia Pazmino, Delphine Bertrand, Veerle Stouten, Claudia Neys, Nelly Creten, Els Van Laeken, Patrick Verschueren, Diederik De Cock, Michaël Doumen, René Westhovens, Sofia Pazmino, Delphine Bertrand, Veerle Stouten, Claudia Neys, Nelly Creten, Els Van Laeken, Patrick Verschueren, Diederik De Cock

Abstract

Background: Shifts in treatment strategies for rheumatoid arthritis (RA) have made ambulatory care more labour-intensive. These developments have prompted innovative care models, including mobile health (mHealth) applications. This study aimed to explore the perceptions of mHealth-inexperienced stakeholders concerning these applications in RA care.

Methods: We performed a qualitative study by focus group interviews of stakeholders including RA patients, nurses specialised in RA care and rheumatologists. The qualitative analysis guide of Leuven (QUAGOL), which is based on grounded theory principles, was used to thematically analyse the data. In addition, the Persuasive Systems Design (PSD) model was used to structure recommended app-features.

Results: In total, 2 focus groups with nurses (total n = 16), 2 with patients (n = 17) and 2 with rheumatologists (n = 25) took place. Six overarching themes emerged from the analysis. Efficiency of care and enabling patient empowerment were the two themes considered as expected benefits of mHealth-use in practice by the stakeholders. In contrast, 4 themes emerged as possible barriers of mHealth-use: the burden of chronic app-use, motivational aspects, target group aspects, and legal and organisational requirements. Additionally, recommendations for an ideal mHealth-app could be structured into 4 domains (Primary Task Support, Dialogue Support, Social Support and System Credibility) according to the PSD-framework. Most recommended features were related to improving ease of use (Task Support) and System Credibility.

Conclusions: Although mHealth-apps were expected to improve care efficiency and stimulate patient empowerment, stakeholders were concerned that mHealth-app use could reinforce negative illness behaviour. For mHealth-apps to be successful in practice, challenges according to stakeholders were avoiding long-term poor compliance, finding the target audience and tailoring a legal and organisational framework. Finally, the ideal mHealth-application should above all be trustworthy and easy to use.

Keywords: Care innovations; Focus groups; Mobile apps; Perceptions; Qualitative; Rheumatoid arthritis; Stakeholders; eHealth; mHealth.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2021. The Author(s).

References

    1. Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, et al. Rheumatoid arthritis. Nat Rev Dis Primers. 2018;4:18001. doi: 10.1038/nrdp.2018.1.
    1. Smolen JS, Landewé RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020;79(6):685–99. doi: 10.1136/annrheumdis-2019-216655.
    1. Van Der Linden MPM, Le Cessie S, Raza K, Van Der Woude D, Knevel R, Huizinga TWJ, et al. Long-term impact of delay in assessment of patients with early arthritis. Arthritis Rheum. 2010;62(12):3537–46. doi: 10.1002/art.27692.
    1. van der Elst K, Verschueren P, Stouten V, Pazmino S, de Groef A, de Cock D, et al. Patient-reported outcome data from an early rheumatoid arthritis trial: opportunities for broadening the scope of treating to target. Arthritis Care Res. 2019;71(12):1566–75. doi: 10.1002/acr.23900.
    1. Delaurier A, Bernatsky S, Baron M, Légaré J, Feldman DE. Wait times for rheumatology consultation: Is rheumatoid arthritis prioritized? J Clin Rheumatol. 2012;18(7):341–4. doi: 10.1097/RHU.0b013e31826d6408.
    1. Battafarano DF, Ditmyer M, Bolster MB, Fitzgerald JD, Deal C, Bass AR, et al. 2015 American College of Rheumatology Workforce Study: Supply and Demand Projections of Adult Rheumatology Workforce, 2015–2030. Arthritis Care Res. 2018;70(4):617–26. doi: 10.1002/acr.23518.
    1. Stamm T, Hill J. Extended roles of non-physician health professionals and innovative models of care within Europe: Results from a web-based survey. Musculoskelet Care. 2011;9:93–101. doi: 10.1002/msc.201.
    1. Najm A, Gossec L, Weill C, Benoist D, Berenbaum F, Nikiphorou E. Mobile health apps for self-management of rheumatic and musculoskeletal diseases: systematic literature review. J Med Internet Res. 2019;7(11):e14730.
    1. Davergne T, Rakotozafiarison A, Servy H, Gossec L. Wearable activity trackers in the management of rheumatic diseases: Where are we in 2020? Sensors (Switzerland) 2020;20(17):1–18. doi: 10.3390/s20174797.
    1. Van Riel P, Alten R, Combe B, Abdulganieva D, Bousquet P, Courtenay M, et al. Improving inflammatory arthritis management through tighter monitoring of patients and the use of innovative electronic tools. RMD Open. 2016;2(2):1–9.
    1. Austin L, Sharp CA, van der Veer SN, Machin M, Humphreys J, Mellor P, et al. Providing “the bigger picture”: Benefits and feasibility of integrating remote monitoring from smartphones into the electronic health record. Rheumatology. 2020;59(2):367–78. doi: 10.1093/rheumatology/kez207.
    1. Pers Y-M, Valsecchi V, Mura T, Aouinti S, Filippi N, Marouen S, et al. A randomized prospective open-label controlled trial comparing the performance of a connected monitoring interface versus physical routine monitoring in patients with rheumatoid arthritis. Rheumatology. 2021;60(4):1659–68. doi: 10.1093/rheumatology/keaa462.
    1. Müskens WD, Rongen-van Dartel SAA, Vogel C, Huis A, Adang EMM, van Riel PLCM. Telemedicine in the management of rheumatoid arthritis: maintaining disease control with less healthcare utilization. Rheumatol Adv Pract. 2021;5(1):rkaa079. doi: 10.1093/rap/rkaa079.
    1. Najm A, Lempp H, Gossec L, Berenbaum F, Nikiphorou E. Needs, experiences, and views of people with rheumatic and musculoskeletal diseases on self-management mobile health apps: Mixed methods study. JMIR mHealth uHealth. 2020;8(4):1–12. doi: 10.2196/14351.
    1. Najm A, Nikiphorou E, Kostine M, Richez C, Pauling JD, Finckh A, et al. EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases. RMD Open. 2019;5(2):1–7. doi: 10.1136/rmdopen-2019-001014.
    1. Navarro-Millán I, Zinski A, Shurbaji S, Johnson B, Fraenkel L, Willig J, et al. Perspectives of rheumatoid arthritis patients on electronic communication and patient-reported outcome data collection: a qualitative study. Arthritis Care Res. 2019;71(1):80–7. doi: 10.1002/acr.23580.
    1. Grainger R, Townsley H, White B, Langlotz T, Taylor WJ. Apps for people with rheumatoid arthritis to monitor their disease activity: A review of apps for best practice and quality. JMIR mHealth and uHealth. 2017;5(2):e7.
    1. Seppen BF, Den Boer P, Wiegel J, ter Wee MM, Van der Leeden M, De Vries R, et al. Asynchronous mhealth interventions in rheumatoid arthritis: Systematic scoping review. JMIR mHealth uHealth. 2020;8(11):1–11. doi: 10.2196/19260.
    1. Wei Y, Zheng P, Deng H, Wang X, Li X, Fu H. Design features for improving mobile health intervention user engagement: Systematic review and thematic analysis. J Med Internet Res. 2020;22(12):e21687. doi: 10.2196/21687.
    1. Kitzinger J. Qualitative research: introducing focus groups. BMJ. 1995;311(7000):299–302. doi: 10.1136/bmj.311.7000.299.
    1. Dierckx de Casterle B, Gastmans C, Bryon E, Denier Y. QUAGOL: a guide for qualitative data analysis. Int J Nurs Stud. 2012;49(3):360–71. doi: 10.1016/j.ijnurstu.2011.09.012.
    1. Oinas-Kukkonen H, Harjumaa M. Persuasive systems design: key issues, process model, and system features. Commun Assoc Inform Syst. 2009;24(1):28.
    1. Geuens J, Swinnen TW, Westhovens R, de Vlam K, Geurts L, vanden Abeele V. A review of persuasive principles in mobile apps for chronic arthritis patients: opportunities for improvement. JMIR mHealth uHealth. 2016;4(4):1–15. doi: 10.2196/mhealth.6286.
    1. Wildeboer G, Kelders SM, van Gemert-Pijnen JEWC. The relationship between persuasive technology principles, adherence and effect of web-Based interventions for mental health: a meta-analysis. Int J Med Inform. 2016;96:71–85. doi: 10.1016/j.ijmedinf.2016.04.005.
    1. Lehto T, Oinas-Kukkonen H. Persuasive features in web-based alcohol and smoking interventions: a systematic review of the literature. J Med Internet Res. 2011;13(3):e46. doi: 10.2196/jmir.1559.
    1. Kelders SM, Kok RN, Ossebaard HC, van Gemert-Pijnen JEWC. Persuasive system design does matter: a systematic review of adherence to web-based interventions. J Med Internet Res. 2012;14(6):e152. doi: 10.2196/jmir.2104.
    1. Grainger R, Townsley HR, Ferguson CA, Riley FE, Langlotz T, Taylor WJ. Patient and clinician views on an app for rheumatoid arthritis disease monitoring: Function, implementation and implications. Int J Rheum Dis. 2020;23(6):813–27. doi: 10.1111/1756-185X.13850.
    1. Renskers L, Rongen-Van Dartel SAA, Huis AMP, Van Riel PLCM. Patients’ experiences regarding self-monitoring of the disease course: An observational pilot study in patients with inflammatory rheumatic diseases at a rheumatology outpatient clinic in the Netherlands. BMJ Open. 2020;10(8):1–9. doi: 10.1136/bmjopen-2019-033321.
    1. Petrie KJ, Jago LA, Devcich DA. The role of illness perceptions in patients with medical conditions. Curr Opin Psychiatr. 2007;20(2):163–7. doi: 10.1097/YCO.0b013e328014a871.
    1. Seppen BF, Wiegel J, L’ami MJ, dos Santos Rico SD, Catarinella FS, Turkstra F, et al. Feasibility of self-monitoring rheumatoid arthritis with a smartphone app: results of two mixed-methods pilot studies. JMIR Form Res. 2020;4(9):1–10. doi: 10.2196/20165.
    1. Druce KL, McBeth J, van der Veer SN, Selby DA, Vidgen B, Georgatzis K, et al. Recruitment and ongoing engagement in a UK smartphone study examining the association between weather and pain: cohort study. JMIR mHealth uHealth. 2017;5(11):e168. doi: 10.2196/mhealth.8162.
    1. Druce KL, Dixon WG, McBeth J. Maximizing engagement in mobile health studies: lessons learned and future directions. Rheum Dis Clin North Am. 2019;45(2):159–72. doi: 10.1016/j.rdc.2019.01.004.
    1. Colls J, Lee YC, Xu C, Corrigan C, Lu F, Marquez-Grap G, et al. Patient adherence with a smartphone app for patient-reported outcomes in rheumatoid arthritis. Rheumatology. 2021;60(1):108–12. doi: 10.1093/rheumatology/keaa202.
    1. Sandhu S, Veinot P, Embuldeniya G, Brooks S, Sale J, Huang S, et al. Peer-to-peer mentoring for individuals with early inflammatory arthritis: feasibility pilot. BMJ Open. 2013;3(3):e002267. doi: 10.1136/bmjopen-2012-002267.
    1. Van der Elst K, Bangels L, Peerlings L, Caluwé L, de Langers I, Stouten V, et al. AB1351 do we need a patient peer mentor program in daily practice for patients with early rheumatoid arthritis and if so, how should this be organized? Ann Rheum Dis. 2019;78(Suppl 2):2140LP–2140.
    1. O’Higgins S, Stinson J, Ahola Kohut S, Caes L, Heary C, McGuire BE. Lending an Ear: IPeer2Peer plus Teens Taking Charge online self-management to empower adolescents with arthritis in Ireland: protocol for a pilot randomised controlled trial. BMJ Open. 2019;9(12):e027952. doi: 10.1136/bmjopen-2018-027952.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться